調査レポート | • レポートコード：QYR2104Z3281 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、鉄剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、IV薬）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・鉄剤の市場動向 ・企業の競争状況、市場シェア ・鉄剤の種類別市場規模（経口薬、IV薬） ・鉄剤の用途別市場規模（病院、ドラッグストア、その他） ・鉄剤の北米市場規模2016-2027（アメリカ、カナダ） ・鉄剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・鉄剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鉄剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・鉄剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、AMAG Pharmaceuticals、Daiichi Sankyo、Pharmacosmos、Vifor Pharma、Galenica、Nippon Shinyaku、Sanofi、Wanbang Biopharmaceutical） ・結論 |
Iron is required to transport oxygen through haemoglobin in red blood cells (RBCs) and oxidize cells through cytochrome. Iron deficiency is a common cause of anaemia. Iron drugs are used to treat people with iron deficiency.
In terms of geographic regions, the North Americas accounted for the major share in the market in 2017. The growing awareness of iron drugs in the region is the major cause for the growth of the market.
Market Analysis and Insights: Global Iron Drugs Market
The global Iron Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Iron Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Iron Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Iron Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Iron Drugs market.
Global Iron Drugs Scope and Market Size
Iron Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Iron Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral Drug
IV Drug
Segment by Application
Hospital
Drugstore
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
AMAG Pharmaceuticals
Daiichi Sankyo
Pharmacosmos
Vifor Pharma
Galenica
Nippon Shinyaku
Sanofi
Wanbang Biopharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Iron Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Drug
1.2.3 IV Drug
1.3 Market by Application
1.3.1 Global Iron Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drugstore
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Iron Drugs Market Perspective (2016-2027)
2.2 Iron Drugs Growth Trends by Regions
2.2.1 Iron Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Iron Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Iron Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Iron Drugs Industry Dynamic
2.3.1 Iron Drugs Market Trends
2.3.2 Iron Drugs Market Drivers
2.3.3 Iron Drugs Market Challenges
2.3.4 Iron Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Iron Drugs Players by Revenue
3.1.1 Global Top Iron Drugs Players by Revenue (2016-2021)
3.1.2 Global Iron Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Iron Drugs Revenue
3.4 Global Iron Drugs Market Concentration Ratio
3.4.1 Global Iron Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Iron Drugs Revenue in 2020
3.5 Iron Drugs Key Players Head office and Area Served
3.6 Key Players Iron Drugs Product Solution and Service
3.7 Date of Enter into Iron Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Iron Drugs Breakdown Data by Type
4.1 Global Iron Drugs Historic Market Size by Type (2016-2021)
4.2 Global Iron Drugs Forecasted Market Size by Type (2022-2027)
5 Iron Drugs Breakdown Data by Application
5.1 Global Iron Drugs Historic Market Size by Application (2016-2021)
5.2 Global Iron Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Iron Drugs Market Size (2016-2027)
6.2 North America Iron Drugs Market Size by Type
6.2.1 North America Iron Drugs Market Size by Type (2016-2021)
6.2.2 North America Iron Drugs Market Size by Type (2022-2027)
6.2.3 North America Iron Drugs Market Size by Type (2016-2027)
6.3 North America Iron Drugs Market Size by Application
6.3.1 North America Iron Drugs Market Size by Application (2016-2021)
6.3.2 North America Iron Drugs Market Size by Application (2022-2027)
6.3.3 North America Iron Drugs Market Size by Application (2016-2027)
6.4 North America Iron Drugs Market Size by Country
6.4.1 North America Iron Drugs Market Size by Country (2016-2021)
6.4.2 North America Iron Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Iron Drugs Market Size (2016-2027)
7.2 Europe Iron Drugs Market Size by Type
7.2.1 Europe Iron Drugs Market Size by Type (2016-2021)
7.2.2 Europe Iron Drugs Market Size by Type (2022-2027)
7.2.3 Europe Iron Drugs Market Size by Type (2016-2027)
7.3 Europe Iron Drugs Market Size by Application
7.3.1 Europe Iron Drugs Market Size by Application (2016-2021)
7.3.2 Europe Iron Drugs Market Size by Application (2022-2027)
7.3.3 Europe Iron Drugs Market Size by Application (2016-2027)
7.4 Europe Iron Drugs Market Size by Country
7.4.1 Europe Iron Drugs Market Size by Country (2016-2021)
7.4.2 Europe Iron Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Iron Drugs Market Size (2016-2027)
8.2 Asia-Pacific Iron Drugs Market Size by Type
8.2.1 Asia-Pacific Iron Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Iron Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Iron Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Iron Drugs Market Size by Application
8.3.1 Asia-Pacific Iron Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Iron Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Iron Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Iron Drugs Market Size by Region
8.4.1 Asia-Pacific Iron Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Iron Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Iron Drugs Market Size (2016-2027)
9.2 Latin America Iron Drugs Market Size by Type
9.2.1 Latin America Iron Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Iron Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Iron Drugs Market Size by Type (2016-2027)
9.3 Latin America Iron Drugs Market Size by Application
9.3.1 Latin America Iron Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Iron Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Iron Drugs Market Size by Application (2016-2027)
9.4 Latin America Iron Drugs Market Size by Country
9.4.1 Latin America Iron Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Iron Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Iron Drugs Market Size (2016-2027)
10.2 Middle East & Africa Iron Drugs Market Size by Type
10.2.1 Middle East & Africa Iron Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Iron Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Iron Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Iron Drugs Market Size by Application
10.3.1 Middle East & Africa Iron Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Iron Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Iron Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Iron Drugs Market Size by Country
10.4.1 Middle East & Africa Iron Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Iron Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Iron Drugs Introduction
11.1.4 Allergan Revenue in Iron Drugs Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 AMAG Pharmaceuticals
11.2.1 AMAG Pharmaceuticals Company Details
11.2.2 AMAG Pharmaceuticals Business Overview
11.2.3 AMAG Pharmaceuticals Iron Drugs Introduction
11.2.4 AMAG Pharmaceuticals Revenue in Iron Drugs Business (2016-2021)
11.2.5 AMAG Pharmaceuticals Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Details
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Iron Drugs Introduction
11.3.4 Daiichi Sankyo Revenue in Iron Drugs Business (2016-2021)
11.3.5 Daiichi Sankyo Recent Development
11.4 Pharmacosmos
11.4.1 Pharmacosmos Company Details
11.4.2 Pharmacosmos Business Overview
11.4.3 Pharmacosmos Iron Drugs Introduction
11.4.4 Pharmacosmos Revenue in Iron Drugs Business (2016-2021)
11.4.5 Pharmacosmos Recent Development
11.5 Vifor Pharma
11.5.1 Vifor Pharma Company Details
11.5.2 Vifor Pharma Business Overview
11.5.3 Vifor Pharma Iron Drugs Introduction
11.5.4 Vifor Pharma Revenue in Iron Drugs Business (2016-2021)
11.5.5 Vifor Pharma Recent Development
11.6 Galenica
11.6.1 Galenica Company Details
11.6.2 Galenica Business Overview
11.6.3 Galenica Iron Drugs Introduction
11.6.4 Galenica Revenue in Iron Drugs Business (2016-2021)
11.6.5 Galenica Recent Development
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Details
11.7.2 Nippon Shinyaku Business Overview
11.7.3 Nippon Shinyaku Iron Drugs Introduction
11.7.4 Nippon Shinyaku Revenue in Iron Drugs Business (2016-2021)
11.7.5 Nippon Shinyaku Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Iron Drugs Introduction
11.8.4 Sanofi Revenue in Iron Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Wanbang Biopharmaceutical
11.9.1 Wanbang Biopharmaceutical Company Details
11.9.2 Wanbang Biopharmaceutical Business Overview
11.9.3 Wanbang Biopharmaceutical Iron Drugs Introduction
11.9.4 Wanbang Biopharmaceutical Revenue in Iron Drugs Business (2016-2021)
11.9.5 Wanbang Biopharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Iron Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Drug
Table 3. Key Players of IV Drug
Table 4. Global Iron Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Iron Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Iron Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Iron Drugs Market Share by Regions (2016-2021)
Table 8. Global Iron Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Iron Drugs Market Share by Regions (2022-2027)
Table 10. Iron Drugs Market Trends
Table 11. Iron Drugs Market Drivers
Table 12. Iron Drugs Market Challenges
Table 13. Iron Drugs Market Restraints
Table 14. Global Iron Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Iron Drugs Market Share by Players (2016-2021)
Table 16. Global Top Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Drugs as of 2020)
Table 17. Ranking of Global Top Iron Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Iron Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Iron Drugs Product Solution and Service
Table 21. Date of Enter into Iron Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Iron Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Iron Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Iron Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Iron Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Iron Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Iron Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Iron Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Iron Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Iron Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Iron Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Iron Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Iron Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Iron Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Iron Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Iron Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Iron Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Iron Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Iron Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Iron Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Iron Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Iron Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Allergan Company Details
Table 62. Allergan Business Overview
Table 63. Allergan Iron Drugs Product
Table 64. Allergan Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 65. Allergan Recent Development
Table 66. AMAG Pharmaceuticals Company Details
Table 67. AMAG Pharmaceuticals Business Overview
Table 68. AMAG Pharmaceuticals Iron Drugs Product
Table 69. AMAG Pharmaceuticals Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 70. AMAG Pharmaceuticals Recent Development
Table 71. Daiichi Sankyo Company Details
Table 72. Daiichi Sankyo Business Overview
Table 73. Daiichi Sankyo Iron Drugs Product
Table 74. Daiichi Sankyo Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 75. Daiichi Sankyo Recent Development
Table 76. Pharmacosmos Company Details
Table 77. Pharmacosmos Business Overview
Table 78. Pharmacosmos Iron Drugs Product
Table 79. Pharmacosmos Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 80. Pharmacosmos Recent Development
Table 81. Vifor Pharma Company Details
Table 82. Vifor Pharma Business Overview
Table 83. Vifor Pharma Iron Drugs Product
Table 84. Vifor Pharma Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 85. Vifor Pharma Recent Development
Table 86. Galenica Company Details
Table 87. Galenica Business Overview
Table 88. Galenica Iron Drugs Product
Table 89. Galenica Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 90. Galenica Recent Development
Table 91. Nippon Shinyaku Company Details
Table 92. Nippon Shinyaku Business Overview
Table 93. Nippon Shinyaku Iron Drugs Product
Table 94. Nippon Shinyaku Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 95. Nippon Shinyaku Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Wanbang Biopharmaceutical Company Details
Table 101. Wanbang Biopharmaceutical Business Overview
Table 102. Wanbang Biopharmaceutical Iron Drugs Product
Table 103. Wanbang Biopharmaceutical Revenue in Iron Drugs Business (2016-2021) & (US$ Million)
Table 104. Wanbang Biopharmaceutical Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Iron Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Drug Features
Figure 3. IV Drug Features
Figure 4. Global Iron Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drugstore Case Studies
Figure 7. Others Case Studies
Figure 8. Iron Drugs Report Years Considered
Figure 9. Global Iron Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Iron Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Iron Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Iron Drugs Market Share by Regions (2022-2027)
Figure 13. Global Iron Drugs Market Share by Players in 2020
Figure 14. Global Top Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Iron Drugs Revenue in 2020
Figure 16. Global Iron Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Iron Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Iron Drugs Market Share by Type (2016-2027)
Figure 20. North America Iron Drugs Market Share by Application (2016-2027)
Figure 21. North America Iron Drugs Market Share by Country (2016-2027)
Figure 22. United States Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Iron Drugs Market Share by Type (2016-2027)
Figure 26. Europe Iron Drugs Market Share by Application (2016-2027)
Figure 27. Europe Iron Drugs Market Share by Country (2016-2027)
Figure 28. Germany Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Iron Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Iron Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Iron Drugs Market Share by Region (2016-2027)
Figure 38. China Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Iron Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Iron Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Iron Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Iron Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Iron Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Iron Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Iron Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Allergan Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 58. AMAG Pharmaceuticals Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 59. Daiichi Sankyo Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 60. Pharmacosmos Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 61. Vifor Pharma Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 62. Galenica Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 63. Nippon Shinyaku Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 65. Wanbang Biopharmaceutical Revenue Growth Rate in Iron Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界のIV・経口鉄剤市場 2021：企業別、地域別、種類・用途別 The IV and Oral Iron Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 世界の静脈内（IV）鉄剤市場 2021：企業別、地域別、種類・用途別 The Intravenous (IV) Iron Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の鉄欠乏性貧血治療薬市場 2021：企業別、地域別、種類・用途別 The Iron Deficiency Anemia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界のイロプロスト薬市場規模・現状・予測（2021年-2027年） Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. North America is estimated to have a major share in the global market with 75%. Market Analysis…
- 世界の貧血治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anemia Drugs Market The global Anemia Drugs market size is projected to reach US$ 15910 million by 2026, from US$ 11620 million in 2019, at a CAGR of 4.5% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a br…